What is Medpace Holdings, Inc.'s depreciation?

Medpace Holdings, Inc. (MEDP) reported depreciation of $6.75M in Q1 2026.

How has Medpace Holdings, Inc.'s depreciation changed year-over-year?

Medpace Holdings, Inc.'s depreciation increased by 0.9% year-over-year, from $6.69M to $6.75M.

What is the long-term trend for Medpace Holdings, Inc.'s depreciation?

Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s depreciation has grown at a 14.2% compound annual growth rate (CAGR), from $16.01M to $27.18M.

Medpace Holdings, Inc. MEDP Depreciation

Depreciation at other companies

West Pharmaceutical ServicesWST

——

Segments

By segment

See full

Reportable Segment$6.75M+0.9%

Other financials

Income statement

See full

Revenue$706.6M+26.5%

Operating income$141.5M+24.6%

Net income$123.9M+8.1%

EPS (diluted)$4.28+16.6%

Balance sheet

See full

Cash & equivalents$652.7M+47.9%

Total debt$146.1M-2.8%

Total equity$598.3M+0.8%

Total assets$2.1B+12.2%

Cash flow

See full

Operating cash flow$151.8M+20.6%

CapEx$6.8M-31.8%

Free cash flow$145.0M+25.1%

Valuation

See full

Market cap$13.14B+46.8%

Enterprise value$12.64B+45.9%

P/E28.6×+7.0×

P/S4.9×+0.8×

Profitability

See full

Operating margin21%-0.1pp

Net margin17.2%-2.1pp

FCF margin26.5%+1.5pp

Returns & leverage

See full

Return on equity77.3%+11.4pp

Debt / equity0.2×0.0×

Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medpace Holdings, Inc.'s depreciation?: Medpace Holdings, Inc. (MEDP) reported depreciation of $6.75M in Q1 2026.
How has Medpace Holdings, Inc.'s depreciation changed year-over-year?: Medpace Holdings, Inc.'s depreciation increased by 0.9% year-over-year, from $6.69M to $6.75M.
What is the long-term trend for Medpace Holdings, Inc.'s depreciation?: Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s depreciation has grown at a 14.2% compound annual growth rate (CAGR), from $16.01M to $27.18M.